Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Century Therapeutics (NASDAQ:IPSC) Reports Lower R&D Spending and USD 174.1 Million in Cash and Investments

Research and development expenses were USD 18.1 million for the quarter, against USD 22.5 million a year earlier. The decrease of USD 4.4 million was partly offset by an increase of USD 0.3 million in research and laboratory expenses. The filing attributes it mainly …

Nitish Kishor | 13 November 2026

Ideal Power (NASDAQ:IPWR) Reports Third-Quarter Net Loss of USD 3.6 Million and Cash of USD 38.3 Million

President and Chief Executive Officer David Somo said customer engagements expanded as the transition to higher-voltage DC architectures is acceleratingDemandfor solid-state circuit protection. He cited a prototype demonstrated with Power Integrations, shipments of new reference design kits and progress with Stellantis.

Nitish Kishor | 13 November 2026

IZEA Worldwide (NASDAQ:IZEA) Reports Third-Quarter Revenue of USD 6.2 Million and Managed Services Bookings Up 94%

Management said overall revenue performance remains below its expectations, and cited the strength of its largest client relationships, the acceleration of contract bookings and continued improvement in operating efficiency.

Nitish Kishor | 13 November 2026

Jefferson Capital (NASDAQ:JCAP) Reports Third-Quarter Revenue of USD 185.5 Million, Up 22.9%, and Net Income of USD 46.9 Million

The 10-Q attributes theRevenueincrease primarily to strong deployment growth in prior periods. The company's common stock trades on theNasdaqGlobal Select Market.

Nitish Kishor | 13 November 2026

Kardigan (NASDAQ:KARD) Reports First Quarterly Filing After IPO and Starts Phase 3 Danicamtiv Trial

The company was incorporated in Delaware in August 2023 under the name EnCarda, Inc. It reported noRevenuefigure for the period.

Nitish Kishor | 13 November 2026

KinderCare Learning Companies (NYSE:KLC) Reports Third-Quarter Revenue of USD 665 Million and Updates 2026 Outlook

Management said lower enrollment across its KinderCare centers continued to pressure revenue, partly offset by growth in Champions and contributions from small group enrichment and newer centers. Average weekly early childhood enrollments declined approximately 6% against the prior year, including a negative impact of …

Nitish Kishor | 13 November 2026

Kodiak Sciences (NASDAQ:KOD) Reports Nine-Month Net Loss of USD 190.0 Million as KSI-501 ALTO Study Begins Enrolling

The filing states that the company has incurred net losses in each reporting period since inception, including a net loss of USD 190.0 million for the nine months ended September 30, 2026. It reports an accumulated deficit of USD 1.7 billion and says it …

Nitish Kishor | 13 November 2026

Katapult Holdings (NASDAQ:KPLT) Reports First Quarter With Combined Aaron's and CCFI Operations

Chief executive Cory Miller said the quarter was defined by speed of execution since theMergerclosed in August. The company has identified approximately USD 30 million in annualized cost synergies and is working onRevenueopportunities across its brands. Gross profit of USD 437.7 million represented a …

Nitish Kishor | 13 November 2026

Knightscope (NASDAQ:KSCP) Reports Third-Quarter Revenue of USD 8.7 Million, Up 177%, Following Security Force Acquisition

The filing says the company acquired Event Risk, which operates as Knightscope Security Force, for total purchase consideration of approximately USD 18.0 million. Following the integration, its chief operating decision maker began reviewing consolidated operating results as a single operating unit rather than two …

Nitish Kishor | 13 November 2026

Kyverna Therapeutics (NASDAQ:KYTX) Completes BLA Submission for Miv-cel in Stiff Person Syndrome

The filing states that the company initiated the rolling BLA submission of miv-cel in stiff person syndrome in the second quarter of 2026 and completed it in the fourth quarter of 2026. It is seeking priority review under the Regenerative Medicine Advanced Therapy designation. …

Nitish Kishor | 13 November 2026
Support

Hi! How can we help you today?

Loading…